ALTSTATION.IO

Emerson Electric Co. (EMR) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price
$155.81
Change
+3.23%
Market Cap
$87.61B
Avg Volume
2.8M

Company Overview

Emerson Electric Co. (EMR) specializes in automation technology and software solutions for a range of industries. They offer products like control valves, pressure gauges, and testing equipment, primarily for process and hybrid industries, discrete manufacturing, and infrastructure. Their customer base is diverse, including companies in sectors such as oil and gas, chemicals, and food and beverage, looking to improve operational efficiency and safety through advanced technology.

Emerson is a prominent player in the industrial automation market, often regarded as a market leader. Their competitive edge stems from a diverse product portfolio and a strong focus on innovation, which is crucial in an industry marked by rapid technological advancements. Key competitors include Rockwell Automation and Honeywell, which also vie for market share in automation. Threats include economic downturns affecting capital spending in industrial sectors and increased competition from emerging players.

Currently, Emerson is in a growth phase, actively pursuing strategic acquisitions to enhance its portfolio. Recent milestones include the acquisition of a leading software company to bolster their digital transformation capabilities and expand their customer offerings. This positioning allows Emerson to adapt to evolving market demands while capitalizing on trends like Industry 4.0 and increased automation in manufacturing.

Key Financials
Market Cap
$87.61B
Revenue
$18.19B
EBITDA
$5.88B
Gross Margin
52.8%
Profit Margin
12.7%
Revenue Growth
4.1%
Total Cash
$1.75B
Total Debt
$14.06B
Free Cash Flow
$2.88B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
38.19
Forward P/E
21.77
Beta
1.25
52-Week High
$160.13
52-Week Low
$90.06
EPS
$4.08
50-Day Avg
$140.62
200-Day Avg
$132.28
Price/Book
4.32
EMR 52-Week Stock Chart
Technical Analysis
The 52-week trend for Emerson Electric Co. (EMR) shows a strong upward direction, with the price increasing from around $120 in February to the current level of $155.81, reflecting a gain of 26.3%. Key support is identified at the $120 level, which was a consistent bounce point, while resistance has formed around $157.38, indicating a potential area of selling pressure. The chart displays a notable ascending triangle formation, suggesting bullish continuation as the price tested resistance in January and February. Recent momentum appears strong, with successive higher lows, especially in the past few weeks as the stock closed above the $150 mark. Currently priced at $155.81, EMR is positioned near its 52-week high, implying increased bullish sentiment and potential for upward breakout above resistance levels.


Recent News and Developments

Here’s a summary of the latest news and developments for Emerson Electric Co

(EMR) stock in the past week (February 1-7, 2026):

1. Emerson Electric Beats Q1 Earnings Expectations and Raises Full-Year Guidance

Emerson Electric (EMR) reported strong financial results for its first quarter ended December 31, 2025, surpassing earnings per share (EPS) forecasts. The company posted an adjusted diluted EPS of $1.46, exceeding the expected $1.41. Sales for the quarter reached $4.35 billion, meeting analysts’ expectations, and the company subsequently raised its full-year fiscal 2026 adjusted EPS guidance to $6.40-$6.55.

2. Wells Fargo Raises Price Target for Emerson Electric Amidst Positive Analyst Sentiment

On February 4, 2026, Wells Fargo maintained its “Equal-Weight” rating for Emerson Electric but increased its price target from $145 to $160, reflecting a positive outlook for the company’s stock. This adjustment aligns with a general trend of heightened price targets from other financial firms for EMR. The median price target among 33 Wall Street analysts is currently $155.00, suggesting a slight upside from its current trading price.

Market Sentiment and Analyst Recommendations

Bull Case
Emerson just raised full-year guidance to $6.40-$6.55 EPS after beating Q1 by 3.5%, which signals management confidence in execution. The 26.3% gain over 52 weeks shows real momentum, and the stock is testing resistance at $157.38 with an ascending triangle pattern suggesting further upside. Revenue growth of 4.1% is modest but the $1.46 Q1 EPS beat proves the company is squeezing margins and converting sales into profit effectively. Wall Street consensus sits at $163.99 target with 27 buy ratings, meaning there’s 5.3% upside to consensus and potentially 29% to the high target of $201. The balance sheet is solid with $1.75B in cash, and at a 38.19 P/E ratio, you’re paying for growth and operational excellence in industrial automation and climate control, sectors seeing steady demand from infrastructure and energy transition investments.
Bear Case
The 38.19 P/E multiple is expensive relative to 4.1% revenue growth, which means the market is pricing in significant margin expansion or growth acceleration that hasn’t materialized yet. Debt sits at $14.06B against just $1.75B cash, giving a net debt position of $12.31B that limits financial flexibility if the economy softens or interest rates stay elevated. The stock already ripped 26.3% in 52 weeks and is near all-time highs, which creates a crowded setup where the risk-reward favors taking profits over buying breakouts. The recent 4.06% drop on February 5 after a 2.33% pop shows volatility and potential profit-taking, suggesting conviction isn’t as strong as the headline earnings beat implies. Industrial demand is cyclical, and if manufacturing activity slows or capex budgets contract in 2026, EMR’s growth will decelerate fast while the valuation multiple compresses.
What to Watch
Monitor Q2 earnings in late April for confirmation that the guidance raise was justified, not just a one-quarter beat. Watch the $157.38 resistance level closely; a break above it targets $165-$170, but a reversal below $150 invalidates the bullish chart setup. Track the debt-to-EBITDA ratio and any capital allocation announcements; if management uses cash for buybacks instead of deleveraging, that’s a yellow flag on confidence. Keep tabs on industrial production data and PMI readings, especially manufacturing orders, as these directly impact Emerson’s backlog and pricing power. The analyst target range is massive ($111 to $201), which means consensus is fragmented; watch for any downgrades from major firms like Wells Fargo, which could trigger a 5-10% pullback quickly. Finally, monitor interest rate expectations and the Fed’s stance; a sustained rise in rates could pressure the valuation multiple even if earnings stay solid.
Analyst Consensus
BUY

Based on 27 analyst opinions
Low Target
$111.00
Mean Target
$163.99
High Target
$201.00


Earnings and Financial Data

Sector
Industrials
Industry
Specialty Industrial Machinery
Employees
71,000


Earnings & Dividends
Next Earnings
Feb 03, 2026
EPS (Trailing)
$4.08
Dividend Yield
143.0%
Payout Ratio
52.4%

Frequently Asked Questions

Is EMR a good stock to buy?
Analysts rate Emerson Electric Co. (EMR) as a BUY with a target price of $163.99. Given its strong market cap of $87.61 billion and consistent dividend payments, EMR presents a solid investment opportunity.
What is EMR’s price target?
The current analyst target for EMR is $163.99. This target reflects a potential upside from the current price of $155.81, indicating a favorable outlook for investors.
Does EMR pay a dividend?
Yes, Emerson Electric Co. has a notable dividend yield of 143.0%. This makes it an attractive option for income-focused investors looking for reliable cash flow.
What is the P/E ratio for EMR?
EMR’s price-to-earnings (P/E) ratio is 38.19, with a forward P/E of 21.77. While the current P/E suggests higher valuations, the forward P/E indicates potential for earnings growth in the near future.
What is the 52-week range for EMR stock?
The 52-week range for EMR is between $90.06 and $160.13. Currently, the stock is trading near its high, which may indicate strong investor confidence and stability within the company.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.